domingo, 16 de junio de 2019

Cystic Fibrosis News Today Weekly Digest


Cystic Fibrosis Weekly Update

Contents:

Bronchitol, Inhalation Powder for CF Patients, to Enter Swiss Market

Jun 14, 2019 07:00 am | Joana Carvalho



CF treatment enters Swiss marketEffRx Pharmaceuticals announced that it has signed an exclusive license agreement with Pharmaxis to register and commercialize Bronchitol (mannitol) for the treatment of cystic fibrosis (CF) in Switzerland. According to EffRx, Bronchitol should be available to Swiss patients by 2021. Bronchitol is a dry powder for inhalation developed by Pharmaxis, an Australian company. After being inhaled, […]
The post Bronchitol, Inhalation Powder for CF Patients, to Enter Swiss Market appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike Bronchitol, Inhalation Powder for CF Patients, to Enter Swiss Market on Facebook

31 Days of CF: Catherine’s Story

Jun 13, 2019 12:00 pm | Luisa Palazola



View this post on Instagram ⁣Day 20 of 31 Days of CF ⁣ Topic: Guide to University ⁣ ⁣ The lovely @catheriine98 is currently studying to be a school teacher. Here are a few things she’s learned from her uni experience:⁣ ⁣ CF Clinics⁣ Before I left for uni, I met with the CF team […]
The post 31 Days of CF: Catherine’s Story appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike 31 Days of CF: Catherine’s Story on Facebook

Murepavadin Antibiotic Well-tolerated by Animals Infected with Pseudomonas Aeruginosa, Preclinical Data Show

Jun 13, 2019 07:00 am | Joana Carvalho



Murepavadin, CFMurepavadin (POL7080), Polyphor‘s lead investigational antibiotic targeting Gram-negative bacteria, behaved as expected and was well-tolerated when administered to mice harboring a lung infection caused by Pseudomonas aeruginosa, data from a preclinical study show. Of note, P. aeruginosa is a bacteria that often infects the lungs of patients with cystic fibrosis (CF). The findings were presented in […]
The post Murepavadin Antibiotic Well-tolerated by Animals Infected with Pseudomonas Aeruginosa, Preclinical Data Show appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike Murepavadin Antibiotic Well-tolerated by Animals Infected with Pseudomonas Aeruginosa, Preclinical Data Show on Facebook

31 Days of CF: Aoife’s Story

Jun 12, 2019 12:00 pm | Luisa Palazola



View this post on Instagram Day 18 of 31 Days of CF ⁣ CF and Travel ⁣ ⁣ This is Aoife’s experience: ⁣ ⁣ It all started with a family trip to The Land Down Undah when I was just 13 years old. There was something about the energy in Sydney. Coming from my little […]
The post 31 Days of CF: Aoife’s Story appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike 31 Days of CF: Aoife’s Story on Facebook
 

Recent News

Inhaled Imipenem/cilastatin an Alternative Treatment for Lung Infection in Children with CF, Case Reports Show
To the Child I’ll Never Have
31 Days of CF: Nick’s Story
Kalydeco Restored Pancreatic Function in Boy with CF, Case Report Suggests
31 Days of CF: Genesis’ Story

No hay comentarios:

Publicar un comentario